What dose of Metformin and Kidneys is used at eGFR 30–44?

At 30–44 mL/min/1.73m² (or CrCl 30–50), the recommended dose of Metformin and Kidneys is: Do NOT initiate; if already on metformin, continue at reduced dose.

Is Metformin and Kidneys safe in kidney disease at eGFR 30–44?

FDA guidance: do not start at eGFR 30-45. If already taking it, continue reduced and reassess kidney function within 3 months. This table is dosing guidance for planning — the final dose is confirmed by your prescriber, and kidney function and the drug's own monitoring requirements are rechecked regularly.

What should I check while taking Metformin and Kidneys at eGFR 30–44?

Follow the drug's label monitoring — typically kidney function (eGFR/creatinine), and for many drugs potassium, drug levels, or blood counts as applicable. Report any new symptoms such as weakness, irregular heartbeat, or unusual side effects to your doctor.

What dose of Metformin and Kidneys is used at eGFR 30–44?

At 30–44 mL/min/1.73m² (or CrCl 30–50), the recommended dose of Metformin and Kidneys is: Do NOT initiate; if already on metformin, continue at reduced dose.

Is Metformin and Kidneys safe in kidney disease at eGFR 30–44?

FDA guidance: do not start at eGFR 30-45. If already taking it, continue reduced and reassess kidney function within 3 months. This table is dosing guidance for planning — the final dose is confirmed by your prescriber, and kidney function and the drug's own monitoring requirements are rechecked regularly.

What should I check while taking Metformin and Kidneys at eGFR 30–44?

Follow the drug's label monitoring — typically kidney function (eGFR/creatinine), and for many drugs potassium, drug levels, or blood counts as applicable. Report any new symptoms such as weakness, irregular heartbeat, or unusual side effects to your doctor.

Renal Dosing Guide

Metformin and Kidneys Dosing at eGFR 30–44

Glucophage • Biguanide • Kidney function: 30–44 mL/min/1.73m² (or CrCl 30–50)

The recommended dose of Metformin and Kidneys at 30–44 mL/min/1.73m² (or CrCl 30–50) — with monitoring notes for kidney disease and dialysis.

Recommended dose at eGFR 30–44

Do NOT initiate; if already on metformin, continue at reduced dose.

FDA guidance: do not start at eGFR 30-45. If already taking it, continue reduced and reassess kidney function within 3 months.

Dosing at Other Kidney Function Levels

Metformin and Kidneys at eGFR ≥45

≥45 mL/min/1.73m² (or CrCl >50)

View dose

Metformin and Kidneys at eGFR 15–29

15–29 mL/min/1.73m² (or CrCl 15–29)

View dose

Metformin and Kidneys at eGFR <15

<15 mL/min/1.73m² (not on dialysis)

View dose

Metformin and Kidneys at On dialysis

Hemodialysis or peritoneal dialysis

View dose

How dosing is decided

Doses in this guide follow drug labels and renal-dosing references at each eGFR/CrCl level. Always confirm with your prescriber and pharmacy — your specific dose depends on other medications, conditions, and lab results.

Full Metformin and Kidneys kidney guide

Monitoring reminder

Metformin and Kidneys has its own monitoring requirements (eGFR, potassium, drug levels, or blood counts). These become more frequent as kidney function falls. Report unusual weakness, irregular heartbeat, or new side effects promptly.

Interactive drug-dosing tool